1995
DOI: 10.1111/j.1471-0528.1995.tb09090.x
|View full text |Cite
|
Sign up to set email alerts
|

Prolactinomas: present day management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1995
1995
2011
2011

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…During this time the management of prolactinomas has evolved. Dopamine agonists have become available and are now the first line treatment for patients such as those in this study (Soule & Jacobs, 1995). Bromocriptine was the most frequently used dopamine agonist in this study.…”
Section: Discussionmentioning
confidence: 99%
“…During this time the management of prolactinomas has evolved. Dopamine agonists have become available and are now the first line treatment for patients such as those in this study (Soule & Jacobs, 1995). Bromocriptine was the most frequently used dopamine agonist in this study.…”
Section: Discussionmentioning
confidence: 99%
“…Bromocriptine should therefore be recommended as primary therapy in women with macroprolactinomas 34,35 . However, women with macroprolactinomas should be advised against conception until normal visual fields are documented and a repeat pituitary magnetic resonance scan has shown tumour shrinkage to within the pituitary fossa, which may take three to six months.…”
Section: Treatment Of Prolactinomas During Pregnancymentioning
confidence: 99%
“…In most patients with hyperprolactinaemia bromocriptine lowers prolactin levels, restores gonadal function, stops galactorrhoea and if a prolactinoma is present, causes it to shrink 1 , 2. Bromocriptine is usually given daily by mouth in two or three divided doses.…”
Section: The Drugsmentioning
confidence: 99%